Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression
Open Access
- 5 May 2008
- journal article
- Published by Springer Nature in Cancer Cell International
- Vol. 8 (1) , 6
Abstract
Background: Breast cancer is the most common cause of cancer death in the western world. The expression differences of many proteins are associated with breast cancer progression or suppression. The purpose of the study was to determine the expression of nm23 protein in the invasion status and metastatic potential of breast cancer by using tissue microarray and to determine its role in breast cancer based on the expression of nm23 gene product. Method: nm23 protein expression was examined by immunohistochemistry (IHC) using commercially available tissue microarray containing malignant and normal breast tissues from 216 patients. Results: a similar percentage of cases showed positive cytoplasmic/nuclear staining for nm23 in normal breast tissue (85.7%), primary breast carcinoma node negative (97.5%) and carcinoma with lymph node metastasis (92.1%). Nuclear localization of staining for nm23 protein was higher in infiltrating ductal carcinoma (IDC) node positive (24.3%) and in matched lymph mode metastasis (18.9%) compared to IDC node negative (4.9%). Strong intensity of cytoplasmic/nucleus staining was observed in IDC node negative (42.6%), in IDC node positive (57.1%), and Infiltrating lobular carcinoma (ILC) node negative (44%) compared to normal breast tissue (16.7%). Conclusion: nm23 protein expression appears widely expressed in normal breast, early and advanced breast cancer stages. Interestingly our study found that strong staining intensity and nuclear localization of nm23 protein may prove to be a useful marker of breast cancer progression.Keywords
This publication has 25 references indexed in Scilit:
- Fuzzy rough sets hybrid scheme for breast cancer detectionImage and Vision Computing, 2007
- p53 is a regulator of the metastasis suppressor gene Nm23‐H1Molecular Carcinogenesis, 2003
- Nm23 Gene Product Expression in Invasive Breast CancerActa Oncologica, 2002
- Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.Gut, 1995
- Immunohistochemical Analysis of nm23/NDP Kinase Expression in Human Lung Adenocarcinoma: Association with Tumor Progression in Clara Cell TypeJapanese Journal of Cancer Research, 1994
- nm23—A metastasis suppressor gene?The Journal of Pathology, 1994
- Expression of humannm23-H1 andnm23-H2 proteins in hepatocellular carcinomaCancer, 1994
- Reduced expression of nm23‐H1, but not of nm23‐H2, is concordant with the frequency of lymph‐node metastasis of human breast cancerInternational Journal of Cancer, 1993
- Positive Relationship Between Expression of Anti-metastatic Factor (nm23 Gene Product or Nucleoside Diphosphate Kinase) and Good Prognosis in Human Breast CancerJNCI: Journal of the National Cancer Institute, 1991
- The pattern of metastases in human breast cancer: Methodological aspects and influence of prognostic factorsCancer Treatment Reviews, 1990